



The burden of substance use disorders in Nigeria is huge 
and could be considered an emerging epidemic with myriad 
consequences in the various domains of the society.[1,2] Of 
importance is that the population most affected constitute 
largely the workforce of any country with attendant effects on 
the economy.[1] Despite its implications for the individuals and 
their families and the country at large, there is a large unmet need 
for treatment, as majority of those who have the problem do not 
access the available services.[3] Harm reduction strategies (HRS) 
as a viable alternative to the traditional abstinence-based method 
of dealing with substance abuse is gaining popularity in the 
developed countries. In addition, studies on HRS have shown 
robust empirical support in reducing the negative consequences 
associated with substance use.[4-6] It has been defined “as policies, 
programs, and practices designed to reduce negative physical, 
social, and economic consequences resulting from substance 
use without requiring abstinence as a primary treatment 
goal.”[7] Harm reduction services (HRS) are increasingly being 
recognized across the continuum of health-care services.
HRS is generally lacking in most countries in the sub-Saharan 
Africa;[8] however, a recent global report from the harm 
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reduction international indicates that the sub-region has made 
some progress in the HRS with about 10 countries in the region 
having explicit policy documents supporting it in 2018.[8] 
It appears from this report that countries in Southern and 
Eastern African are more receptive to HRS than West African 
countries. Despite the high prevalence of use of drugs such 
as heroine (63%) and cocaine (70%) among intravenous drug 
users, as well as the unsafe practices such as sharing and re-use 
of needles in Nigeria,[8] HRS has been resisted for several 
reasons including sociocultural and political factors. However, 
in 2018, the Federal Ministry of Health began a consultation 
on the development of guidelines on the use of methadone for 
drug rehabilitation treatment.[9] In addition, the health minister 
also set up a task force for the implementation of HRS in the 
country.[9] HRS echoes the increasingly global outcry that 
substance use problems should be viewed in light of public 
health. In response to this, the National Drug Law Enforcement 
Agency in partnership with other organizations developed the 
National Drug Control Master Plan.[10] A paradigm shift from 
over-concentration in the supply-reduction-centered activities 
to demand-reduction activities was one of the achievements 
of this partnership.[10]
Despite the numerous benefits of HRS and some shift in 
policies toward the public health approach to drug use, the 
awareness of the end-users and their caregivers, acceptability 
and utilization has a weak evidence base in Nigeria. In 
addition, the specific patients’ and caregivers’ barriers to its 
acceptance have not been evaluated in Nigeria. Such data will 
drive policies and public mental health education on the shift 
in the management of substance abuse disorders in Nigeria. 
Hence, this study was done to examine the following research 
questions:
1. Do patients and family caregivers admitted to the drug 
de-addiction unit of a Nigerian Psychiatric Hospital know 
about HRS?
2. What is the level of acceptance of HRS among patients 
and family caregivers?
3. What are the reasons for the acceptance/rejection of HRS 
by the patients and their family caregivers?
MaterIals and Methods
The study was a descriptive survey carried out among inpatients 
and their family caregivers at the Federal Neuropsychiatric 
Hospital (FNH), Enugu, which is one of the eight specialist 
psychiatric hospitals established by the Federal Government 
of Nigeria. It is located within Enugu metropolis and provides 
mental health care for the South Eastern part of Nigeria 
and neighboring geopolitical zones. The hospital has a bed 
capacity of about 300. There are 6 open wards, 2 private 
wards, and an emergency ward. It is one of the United Nations 
Office on Drug and Crime regional centres for the treatment 
of persons with substance use disorder. Patient participants 
were those admitted for substance use disorders (cannabis, 
opioid, alcohol, and multiple substance dependence). The 
study utilized a total population sample with a convenience 
sampling technique to recruit all in-patients admitted for drug 
dependence within the 1-year period of the study (June, 2018 
to June, 2019). Ethical approval was obtained from the Ethics 
and Research Committee of the institution. The international 
ethical standard was strictly adhered to according to Helsinki 
Declaration. All participants were interviewed when it was 
adjudged by the managing team that the patient was clinically 
stable (i.e. that the patient was in a stable state of functioning, 
in clear consciousness without need for chemical restraint and 
increase in medication dosage). Consent was obtained from all 
the study participants, and it was established by a consultant 
psychiatrist that these participants had the capacity to make 
the decision at the time.
To assess patients’/family caregivers’ awareness and 
acceptance of harm reduction services as a treatment option 
in substance use disorders, the harm reduction survey was 
used.[11] The questions were both closed and open-ended as the 
participants were free to add other reasons if not indicated in the 
options. The harm reduction survey is a questionnaire designed 
from a qualitative research that assessed the availability, 
acceptability, and barriers to four harm reduction services, 
namely needle exchange program, free condom sharing, 
methadone replacement, and moderate drinking. In addition, 
the survey also assesses general understanding of harm 
reduction. The pilot of the survey was conducted with some 
patients, relatives, some health workers in the drug treatment 
unit, and the researcher. As a result, an additional option was 
added to the reasons for rejecting harm reduction (i.e. “it brings 
shame to the family”). The questions assessed both patients’ 
and caregivers’ awareness of HRS, the HRS they are aware 
of, acceptance of HRS as a treatment option in substance use 
disorders, reasons for the acceptance or rejection of HRS. In 
addition, each participant was asked to rate on an 11-point 
scale (0 – very unfavorable and 10 – very favorable) how 
they felt about non-abstinence as a treatment goal. Patients 
and their relatives that looked after the patients in the ward 
or who intermittently visited the patients were interviewed in 
a convenient room within the ward. The questionnaire was 
either self-administered or read aloud for the patient and their 
caregiver to indicate the answer as it applied to him/her. It took 
an average of 5 min to answer the questions. Data were entered 
into the Statistical Package of Social Sciences (IBM-SPSS, 
Armonk, NY: IBM Corp) version 20. Categorical questions 
were described using the frequency tables while the 11-point 
rating was summarized using the mean and median descriptive 
statistics. Mann–Whitney U-test was used to compare the 
rating on acceptance of non-abstinence-based regimen between 
patient and caregiver participants.
results
Participants
The patients were mostly young (mean age of 30.5 [±6.8] 
years), mostly males 30 (88.2%), not living with a partner 
16 (47.1%), with more than six years of education 34 (100.0%). 
A majority had a diagnosis of cannabis dependence and the age 
Nigerian Journal of Medicine ¦ Volume 30 ¦ Issue 4 ¦ July-August 2021 459
Onu, et al.: Acceptance of harm reduction services in Nigeria
at first use was in the adolescence [Table 1]. The caregivers 
were mostly in their middle age (mean age of 44.5 years), 
married 23 (67.6%), and two-third of them were nuclear family 
members, as shown in Table 2.
Awareness of HRS among patients and caregivers
The proportion of patients and caregivers that have heard of 
HRS was 8 (23.5%) and 4 (11.8%), respectively. Among those 
who were aware, controlled drinking and free condom were 
most popular, 8 (100.0%) for each, whereas only 2 (50.0%) and 
0 (0.0%) of the caregivers were aware of moderate drinking 
and free condom sharing, respectively [Table 3].
Acceptance of HRS among patients and caregivers
A majority of the patient participants (64.7%) accepted other 
treatment options aside abstinence. However, only 17.6% of the 
family caregivers accepted a non-abstinence-based treatment 
goal as shown in [Table 4]. Patients rated themselves more 
favorable to acceptance of non-abstinence’ based treatment 
regimen (median score of 9), whereas family caregivers rated 
themselves unfavorable to accepting non-abstinence-based 
treatment regimen (median score of 0) (U = 2750.00, 
P < 0.001), as shown in Table 5.
Reasons for acceptance/rejection of HRS
The most common reasons given by the patients for acceptance 
were that “it respects their decision” and “abstinence being 
unrealistic” (54.5% and 45.5%, respectively). For family 
caregivers, the reasons given for acceptance were mostly 
centered on disease reduction and abstinence being unrealistic 
for some drug users. For both patients and family caregivers, 
the most common reasons for rejecting non-abstinence-based 
treatment options were that they encourage drug use and are 
not acceptable by the community. In addition, family caregivers 
also noted that it brings shame to their family [Table 4].
dIscussIon
The main highlights of the findings of this survey of 
HRS among patients and family caregivers are: first, the 
majority (76.5% and 88.2%), respectively, of the patient 
and caregiver participants were not aware of harm reduction 
services as treatment options for substance use. Second, 
patients were more favourably disposed to accepting non-
abstinence-based treatment goals than family caregivers. 
Third, the common reasons given by patients for accepting 
HRS were that it respected their decision and that abstinence 
was unrealistic (54.5% and 45.5%, respectively), and fourth, 
both patients and caregiver participants cited encouragement of 
use and community concerns as reasons for rejection of HRS.
The findings of this study suggest that the majority (76.5%) of 
the patients and their family caregivers (88.2%) were not aware 
of HRS as a treatment option in substance abuse/dependence. 
Our findings are contrary to reports from Western countries, 
especially Canada and Australia.[12,13] In these countries, 
most studies, polls and surveys have shown increased public 
awareness and approval of different HRS.[12,13] The differences 
in the perception of HRS as a treatment modality in various 
countries may be explained by several factors. First, the belief 
in the causation of diseases is important in determining the 
treatment sought. Societies that hold the biomedical model 
of addiction may be biased toward accepting evidence-based 
methods of treatment such as HRS. This is in contrast to those 
who hold supernatural or moral views as seen among Nigerians 
in this study. Second, the availability and accessibility of 
HRS in some countries could lead to increased contact with 
the end-users which indirectly dispels the myths about such 
Table 1: Sociodemographic and clinical characteristics of 
the study participants (n=34)
Variables Frequency, n (%) Mean (SD)
Age 30.5 (6.8)
Age at first use 19.9 (6.6)














Cannabis dependence 21 (61.8)
Alcohol dependence 7 (20.6)
Opioid dependence 2 (5.9)
Multiple substance use 4 (11.8)
SD: Standard deviation
Table 2: Sociodemographic characteristics of the 
caregiver participants (n=34)
Variables Frequency, n (%) Mean (SD)
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services and increase their acceptance in such societies. The 
non availability of HRS in Nigeria as shown in the present study 
may perpetuate ignorance about the usefulness of this treatment 
modality; the end effect may be non acceptance driven by myths 
rather than facts. Third, the communalism in African societies 
as against individualism in some western countries may also 
affect the differences in the perception of HRS. In other words, 
in communal societies, events or services are examined with 
the prism of the cultural context of the society. Therefore, 
individuals’ perception tends to mirror the collective thinking of 
their cultural milieu. It is likely that in Nigeria where addictive 
behaviours are largely abhorred, participants from this setting 
may respond in a way that is acceptable to their society even 
when it contrasts with their inner wishes.
However, this is consistent with the recent observation that 
HRS is generally lacking in Sub-Saharan Africa and the 
political resistance of the Nigerian government to HRS.[8] 
The lack of awareness among patients and family caregiver 
participants could be explained by diverse factors. First, the 
clinicians’ attitude to HRS may have reduced their ability to 
freely discuss HRS as an option to abstinence from substance 
de-addiction. Despite the paradigm shift from paternalism 
to shared decision making (where patients are supported to 
consider options, to achieve informed preferences), a recent 
report shows that though many clinicians talk about it, only a 
few practice it.[14] In one study, Carlberg-Racich[7] found that 
the receptiveness of HRS among service providers was mixed 
with the most skepticism being expressed by physicians. The 
unwillingness of clinicians to discuss HRS as an option in 
substance abuse treatment may have limited the awareness 
of both patients and family caregivers with respect to harm 
reduction services.[7] Other plausible reasons may be related 
to the culturally influenced perception of drug problems.[15,16] 
When considering the reasons why someone might take 
drugs, psychological and moral explanations generally 
prevail, primarily the assumption that the person is “weak” or 
“immoral.”[15] Thus, the general public often sees problematic 
drug use as an individual problem and not what society should 
be dragged into.[15] Such negative stereotypes/perceptions 
could potentially affect the dissemination of information 
regarding HRS. In addition, political resistance and legislative 
constraints may limit media participation in HRS.[17] All these 
factors may decrease access to HRS information with attendant 
consequences on public awareness.
Despite the low awareness of the study participants to HRS, a 
majority (64.7%) of the patients were willing to accept HRS 
more than their family caregivers (17.6%). This is consistent 
with the finding of Carlberg‑Racich who reported that patients 
were more receptive to harm reduction interventions from 
their service providers and even expressed gratitude for harm 
reduction services information and/or supplies.[7] However, 
some authors have observed varied attitudes towards HRS 
among players in the addiction field.[11] These variations in the 
attitude of patients, family members and even service providers 
may be related to their cultural background, availability of 
HRS, specific HRS and legislations.[11] The unwillingness of 
the family caregivers to accept HRS may be explained by the 
lack of knowledge and socio-cultural factors. For example, 
the commonly cited reasons by family members for rejecting 
HRS were hinged on the thinking that HRS encourages drug 
use (85.7%), community rejection (53.6%), and fears for 
the family name (35.7%). In addition, the understanding 
of the cause of substance dependence which in this study, 
most family members believe is a moral weakness may also 
limit their acceptance of any treatment options other than 
abstinence. Furthermore, the lack of enthusiasm or even the 
rejection of harm reduction services on the part of caregivers 
may be explained in part by the fact that the HRS programs 
examined in this study do not reliably relate to their relatives’ 
drug problems, since majority of the studied population had 
cannabis dependence. Public stigma to substance use and 
indeed other mental health problems in the traditional African 
society may also decrease the chances that family members 
will accept any other treatment options that are not abstinence. 
Sociological studies have identified several factors that may 
limit acceptance of new methods of treatments or any other 
innovation.[18] For example, Rogers identified five processes 
underlying the adoption of a new technology; knowledge, 
persuasion (attitudes), decision, implementation, and 
confirmation.[18] It is likely that most caregivers in our study 
are yet to understand the principles of HRS as shown in their 
poor awareness to make an informed decision about its benefits.
Concerning the reasons given for acceptance or rejection 
of HRS, this study found that most patients’ acceptance of 
HRS was based on the reasons of autonomy and the feeling 
that abstinence was an unrealistic goal; whereas caregivers’ 
rejection of HRS was based on fears of encouraging use and 
Table 3: Awareness of harm reduction strategies among 
patient/caregiver population (n=34)
Variables Frequency, n (%)
Patients
Ever heard about harm reduction services (n=34)
Yes 8 (23.5)
No 26 (76.5)
Type of harm reduction services heard (n=8)
Needle and needle exchange program (NSP) 4 (50.0)
OST 6 (75.0)
Controlled/moderate drinking 8 (100.0)
Free condom 8 (100.0)
Caregivers
Ever heard of harm reduction services (n=34)
Yes 4 (11.8)
No 30 (88.2)
Type of harm reduction services heard (n=4)
Needle and needle exchange program (NSP) 0
OST 2 (50.0)
Controlled/moderate drinking 2 (50.0)
Free condom 0
OST: Opioid substitution therapy, NSP: Needle and syringe program
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Table 5: Rating of the acceptance of the harm reduction services by the patients and caregivers participants (n=34)
Variables Mean (median) score U, p
Patients
How do you feel about nonabstinence as a treatment goal for some drug users? 7.7 (9.0) 2750.00, <0.001
Caregivers
How do you feel about nonabstinence as a treatment goal for some drug users? 2.7 (0.0)
0: Very unfavorable, 10: Very favorable
Table 4: Acceptance of harm reduction as a treatment 








Reasons for acceptance (n=22)
Can reduce disease 2 (9.1)
Enables clients to be more productive 2 (9.1)
Decrease criminality 0
Respects my decision 12 (54.5)
Allow access to counseling 0
Reduction of unwanted pregnancy 0
Abstinence unrealistic 10 (45.5)
Reasons for rejecting harm reduction services (n=12)
It encourages use 10 (83.3)
Not acceptable in the community 7 (58.3)
Caregivers
Would you accept treatment options for your relative 
other than abstinence (n=34)
Yes 6 (17.6)
No 28 (82.4)
Reasons for acceptance (n=6)
Can reduce disease 3 (50.0)
Enables clients to be more productive 1 (16.7)
Decrease criminality 0
Allow access to counseling 0
Reduction of unwanted pregnancy 0
Abstinence unrealistic 3 (50.0)
Reasons for rejecting harm reduction services (n=28)
It encourages use 24 (85.7)
Not acceptable in the community 15 (53.6)
Destroys family name 10 (35.7)
Caregiver’s perception of the cause of SUD (n=34)
Moral weakness 24 (70.6)
Supernatural causation 9 (26.5)
Medical/biological causation 0
Not sure 1 (2.9)
SUD: Substance use disorder
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other sociocultural reasons (perceived community resistance 
and dents to the family name). This result re-echoed both 
clinical and research observations that most patients would 
like to be involved in making decisions about their care.[14] 
Furthermore, the belief that abstinence was unrealistic goal by 
the patient is also in keeping with the principles of HRS that 
considered multiple treatment outcomes other than a narrow 
abstinence based options. In buttressing this point, Denning[19] 
wrote that, “Treatment programs that require abstinence for 
entry and only allow abstinence as a treatment goal are, in 
themselves, harmful because they create barriers to treatment 
for many individuals who might otherwise be helped.” Similar 
to this finding, some other studies have identified community 
resistance to be the most common external barrier to acceptance 
of harm reduction services.[11] An additional reason given 
was the fear of dents to the family name. This is particularly 
important in the traditional African society, where the worth 
of a family is judged by their level of obedience to the societal 
norms. In addition, social exchange between the family and 
other members of the community in most African societies 
may be constricted or even waived for families with relatives 
considered to be deviants (e.g. criminality, substance use, and 
other mental disorders).
Limitations
The relatively small sample size in our study may have limited 
the diversity of opinions. In addition, social desirability bias 
toward such culturally sensitive question may have affected 
the responses of the study participants. Similarly, selection 
bias with few number of female participants may have skewed 
the responses. Another important limitation is also related to 
participants selected. Among the patients studied, the largest 
group (almost 62%) were people with cannabis dependence. 
However, among the harm reduction services examined, there 
were none that directly addressed this group of drug users. 
This may have affected the responses of the patients and their 
caregivers.
conclusIon
The findings of this study show low awareness of HRS as 
a treatment option in Nigeria among the patients and their 
caregivers. However, the finding that most patients are 
receptive to HRS offers some optimism that with sustained 
public education and comprehensive government policies, 
HRS may be acceptable to most Nigerians.
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